We are in the process of upgrading our site. Please kindly cooperate with us.

Published Articles

215,213

Total Articles

285,213

Happy users

1,459,539

Open Access JournalsView More

Medical

Editors-in-Chief View More

General Surgery and Clinical Medicine
Mojtaba Esmailpour Roshan, Dvm,Phd
Editor-in-Chief
Researcher and Lecturer at Payam Noor University of Iran, General Surgery Cancer research ,Veterinary medicine
Islamic Azad University of Garmsar,iran, SEMNAN, IR Iran
Journal of Genetic Engineering and Biotechnology Research
Dr. Md Mahmudul Hasan Khan, PhD
Editor-in-Chief
Scientist (Scientific officer), Genetics and Breeding
Universiti Putra Malaysia (UPM), Malaysia, SELANGOR, Malaysia
Biomedical Science and Clinical Research
Hossein Hosseinkhani
Editor-in-Chief
Shareholder & Owner, Innovation Center for Advanced Technology Matrix, Inc.
USA
General Surgery and Clinical Medicine
Mojtaba Esmailpour Roshan, Dvm,Phd
Editor-in-Chief
Researcher and Lecturer at Payam Noor University of Iran, General Surgery Cancer research ,Veterinary medicine
Islamic Azad University of Garmsar,iran, SEMNAN, IR Iran
Journal of Water Research
Majid Ghassemi
Editor-in-Chief
Professor, Department of Mechanical Engineering
K. N. Toosi University of Technology Vanak Square, Iran
Applied Optics and Laser Technology
Surinder Singh, Ph.D.
Editor-in-Chief
Professor, Electronics & Communication Engg.
Sant Longowal Institute of Engg. & Technology , Longowal, Sangrur, Punjab, India

Latest Articles from "Opast Publisher"

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Is Sentinel Lymph Node Tumor Burden a Prognostic Factor for Disease-Free Survival in Patients with Melanoma of the Trunk and Extremities?

Carlos Lehmann-Mosquera, Raul Suarez-Rodriguez, Patricia Lopez-Correa, Ricardo Sanchez, Samuel David Morales, Mau-ricio Garcia-Mora, Javier Angel-Aristizabal, Ivan Marino-Lozano, Carlos Alfonso Duarte-Torres and Sandra E. Diaz-Casas

International Journal of Cancer Research & Therapy

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

Research Article     Free Accress

Outcomes of Brentuximab Vedotin with or without Bendamustine and Nivolumab in Relapsed or Refractory Hodgkin’s Lymphoma: An Early Experience from Patient Access Programme in India

Jyothi Goutham, Samrudhi Joshi, Shekar Patil, Satheesh Chiradoni Thungappa, Ravi Thippeswamy, Shashidha-ra HP, Nishit Ojha, Amey C Panchal, Yesheswini N Naik, Jayantha Balawardane and Sachin Suresh Jadhav

Advances in Hematology and Oncology Research

List of Pubmed Articles